RWPA
AMGN icon

Richard W. Paul & Associates’s Amgen AMGN Stock Holding History

Richard W. Paul & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8K Sell
45
-25
-36% -$8.91K 0.01% 208
2025
Q4 		$22.9K Sell
70
-9
-11% -$2.85K 0.01% 195
2025
Q3 		$22.3K Buy
79
+3
+4% +$870 0.01% 200
2025
Q2 		$21.2K Buy
76
+9
+13% +$2.55K 0.01% 216
2025
Q1 		$20.9K Buy
67
+11
+20% +$3.25K 0.01% 213
2024
Q4 		$14.6K Buy
56
+14
+33% +$4.15K 0.01% 284
2024
Q3 		$13.5K Sell
42
-24
-36% -$7.85K ﹤0.01% 288
2024
Q2 		$20.6K Buy
66
+18
+38% +$5.29K 0.01% 246
2024
Q1 		$13.6K Sell
48
-8
-14% -$2.34K 0.01% 296
2023
Q4 		$16.1K Sell
56
-45
-45% -$12.3K 0.01% 269
2023
Q3 		$27.1K Sell
101
-4
-4% -$998 0.01% 225
2023
Q2 		$23.3K Buy
105
+39
+59% +$9.05K 0.01% 259
2023
Q1 		$16K Buy
66
+18
+38% +$4.42K 0.01% 291
2022
Q4 		$12.6K Buy
+48
New +$12.9K 0.01% 300

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Richard W. Paul & Associates's AMGN Position: Q1 2026 in Review

Richard W. Paul & Associates reduced its Amgen (AMGN) stake by 36% in Q1 2026, selling an estimated $8.91K and leaving 45 shares worth $15.8K. The position accounts for 0.01% of the portfolio, ranked #208.

Richard W. Paul & Associates first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $27.1K in Q3 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Richard W. Paul & Associates held 45 shares of Amgen worth $15.8K as of Q1 2026.
  • Richard W. Paul & Associates sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
  • Amgen made up 0.01% of Richard W. Paul & Associates's portfolio in Q1 2026, its #208 holding.
  • Richard W. Paul & Associates first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Richard W. Paul & Associates's Amgen position peaked at $27.1K in Q3 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Richard W. Paul & Associates's 13F filing for Q1 2026, filed 13 May 2026.